OR WAIT null SECS
© 2023 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
August 19, 2016
Genetic medicines company WAVE Life Sciences Ltd. (Cambridge, MA) announced that it has appointed Keith Regnante as the company’s Chief Financial Officer.
Mr. Regnante was formerly VP of Finance at Shire where he oversaw finance for R&D. Earlier in his career he was a consultant with Boston Consulting Group.